Literature DB >> 16325474

Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins.

Ronald L Klein1, Robert D Dayton, Nancy J Leidenheimer, Karen Jansen, Todd E Golde, Richard M Zweig.   

Abstract

Adeno-associated virus (AAV) serotype 8 appears to be the strongest of the natural serotypes reported to date for gene transfer in liver and muscle. In this study, we evaluated AAV8 in the brain by several methods, including biophotonic imaging of green fluorescent protein (GFP). In the adult rat hippocampus, levels of GFP expressed were clearly greater with AAV8 than with AAV2 or AAV5 by Western blot and biophotonic imaging and slightly but significantly greater than AAV1 by Western blot. In the substantia nigra, the GFP expression conferred by AAV8 was toxic to dopamine neurons, although toxicity could be avoided with dose titration. At the low dose at which there was no GFP toxicity from the GFP vector, another AAV8 vector for a disease-related (P301L) form of the microtubule-associated protein tau caused a 78% loss of dopamine neurons and significant amphetamine-stimulated rotational behavior. The AAV8 tau vector-induced cell loss was greater than that from AAV2 or AAV5 tau vectors, demonstrating that the increased gene transfer was functional. While the toxicity observed with GFP expression warrants great caution, the efficient AAV8 is promising for animal models of neurodegenerative diseases and potentially as well for gene therapy of brain diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325474      PMCID: PMC2987642          DOI: 10.1016/j.ymthe.2005.10.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  30 in total

1.  Is green fluorescent protein toxic to the living cells?

Authors:  H S Liu; M S Jan; C K Chou; P H Chen; N J Ke
Journal:  Biochem Biophys Res Commun       Date:  1999-07-14       Impact factor: 3.575

2.  PKC modulation of GABAA receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor beta 2 subunit.

Authors:  Dina Herring; RenQi Huang; Meharvan Singh; Glenn H Dillon; Nancy J Leidenheimer
Journal:  Neuropharmacology       Date:  2004-12-02       Impact factor: 5.250

3.  Recombinant adeno-associated virus serotype 2 effectively transduces primary rat brain astrocytes and microglia.

Authors:  Yan Gong; Shuzhen Chen; Christopher F Sonntag; Colin Sumners; Ronald L Klein; Michael A King; Jeffrey A Hughes; Edwin M Meyer
Journal:  Brain Res Brain Res Protoc       Date:  2004-11

4.  AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.

Authors:  Marco A Passini; Shannon L Macauley; Michael R Huff; Tatyana V Taksir; Jie Bu; I-Huan Wu; Peter A Piepenhagen; James C Dodge; Lamya S Shihabuddin; Catherine R O'Riordan; Edward H Schuchman; Gregory R Stewart
Journal:  Mol Ther       Date:  2005-05       Impact factor: 11.454

Review 5.  'Green mice' and their potential usage in biological research.

Authors:  M Ikawa; S Yamada; T Nakanishi; M Okabe
Journal:  FEBS Lett       Date:  1998-06-23       Impact factor: 4.124

6.  Novel tools for production and purification of recombinant adenoassociated virus vectors.

Authors:  D Grimm; A Kern; K Rittner; J A Kleinschmidt
Journal:  Hum Gene Ther       Date:  1998-12-10       Impact factor: 5.695

7.  Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.

Authors:  Hiroyuki Nakai; Sally Fuess; Theresa A Storm; Shin-ichi Muramatsu; Yuko Nara; Mark A Kay
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Tau pathology in a family with dementia and a P301L mutation in tau.

Authors:  S S Mirra; J R Murrell; M Gearing; M G Spillantini; M Goedert; R A Crowther; A I Levey; R Jones; J Green; J M Shoffner; B H Wainer; M L Schmidt; J Q Trojanowski; B Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

9.  Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart.

Authors:  Zhong Wang; Tong Zhu; Chunping Qiao; Liqiao Zhou; Bing Wang; Jian Zhang; Chunlian Chen; Juan Li; Xiao Xiao
Journal:  Nat Biotechnol       Date:  2005-02-27       Impact factor: 54.908

Review 10.  Clinical trials in neurological disorders using AAV vectors: promises and challenges.

Authors:  Ronald J Mandel; Corinna Burger
Journal:  Curr Opin Mol Ther       Date:  2004-10
View more
  102 in total

1.  Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injection.

Authors:  Thomas J Giove; Miguel Sena-Esteves; William D Eldred
Journal:  Exp Eye Res       Date:  2010-08-17       Impact factor: 3.467

2.  Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory.

Authors:  Julio J Ramirez; Winona E Poulton; Erik Knelson; Cole Barton; Michael A King; Ronald L Klein
Journal:  Behav Brain Res       Date:  2010-08-19       Impact factor: 3.332

3.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

4.  Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus.

Authors:  Srinivasan P Venkatachalan; Jeremy D Bushman; José L Mercado; Feyza Sancar; Kelly R Christopherson; Andrew J Boileau
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

Review 5.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

6.  Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.

Authors:  Hemraj B Dodiya; Tomas Bjorklund; James Stansell; Ronald J Mandel; Deniz Kirik; Jeffrey H Kordower
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

7.  Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.

Authors:  James C Dodge; Amanda M Haidet; Wendy Yang; Marco A Passini; Mark Hester; Jennifer Clarke; Eric M Roskelley; Christopher M Treleaven; Liza Rizo; Heather Martin; Soo H Kim; Rita Kaspar; Tatyana V Taksir; Denise A Griffiths; Seng H Cheng; Lamya S Shihabuddin; Brian K Kaspar
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

8.  Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Cynthia G Diaczynsky; Michael F Salvatore
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

9.  AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.

Authors:  Nicholas R Franich; Helen L Fitzsimons; Dahna M Fong; Matthias Klugmann; Matthew J During; Deborah Young
Journal:  Mol Ther       Date:  2008-03-25       Impact factor: 11.454

10.  Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism.

Authors:  S K Powell; N Khan; C L Parker; R J Samulski; G Matsushima; S J Gray; T J McCown
Journal:  Gene Ther       Date:  2016-09-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.